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Abstract  
 
Introduction and hypothesis 
Forty-seven women participated in a pilot study for a multi-centre randomized 
controlled trial of the effectiveness of pelvic floor muscle training (PFMT) for women 
with prolapse.   
Methods 
Women with symptomatic stage I or II prolapse (measured by POP-Q) were 
randomized to a 16-week physiotherapy intervention (PFMT and lifestyle advice) 
(n=23) or a control group receiving a lifestyle advice sheet (n=24).  Symptom severity 
and quality of life were measured via postal questionnaires. Blinded POP-Q was 
performed at baseline and follow-up. 
Results 
Intervention women had significantly greater improvement than controls in prolapse 
symptoms (mean score decrease 3.5 versus 0.1, p=0.021); were significantly more 
likely to have an improved prolapse stage (45% vs 0%, p=0.038) and were 
significantly more likely to say their prolapse was better (63% vs 24%, p=0.012).  
Conclusions 
The data support the feasibility of a substantive trial of PFMT for prolapse. A multi-
centre trial is underway.   
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Brief summary 
A pilot trial of pelvic floor muscle training in women with stage I or II prolapse was 
suggestive of a benefit in terms of improved symptoms and severity. 
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Text 
Introduction 
Pelvic organ prolapse (POP), is a common female condition, characterized by 
symptomatic descent of the vaginal walls, apex or vault from the normal anatomical 
position [1].  Women with prolapse present with a variety of symptoms (vaginal, 
urinary, bowel, back, abdominal and sexual).  The condition is debilitating and can 
greatly affect the sufferer’s daily activities and quality of life (QoL). 
 
Current treatment options for prolapse include surgery and conservative 
management.  The latter is often considered if the prolapse is small or the patient is 
not a good candidate for surgery, but can also be used as an adjunct to surgery.  
Types of conservative intervention include: physical interventions which aim to 
improve pelvic floor muscle function via pelvic floor muscle training (PFMT); 
mechanical interventions which aim to manage the prolapse by supporting the pelvic 
area (e.g. using vaginal pessaries) and lifestyle interventions which seek to avoid 
exacerbation of the prolapse by decreasing intra-abdominal pressure (e.g. weight 
loss and avoiding heavy lifting). 
 
Individualised PFMT for women with prolapse is offered by many physiotherapists 
who specialise in women’s health [2].  PFMT would normally involve teaching of 
pelvic floor exercises, vaginal examination and provision of advice regarding lifestyle 
changes, and may also include the use of biofeedback, or neuromuscular electrical 
stimulation.  There is evidence that PFMT is effective in the treatment of urinary 
incontinence [3]. However, clear evidence of the clinical and cost-effectiveness of 
PFMT in the management of prolapse is lacking.  A Cochrane systematic review [4] 
found only one sizeable trial which included women with prolapse and evaluated a 
physical intervention.  This was a cluster randomized trial of 654 elderly Thai women 
which focused only on anterior prolapse and did not use a standardised measure of 
prolapse, but reported significantly less worsening of prolapse in the group receiving 
pelvic floor exercises and diet/fluid advice [5].  The methodological limitations and 
restricted population in this trial make interpretation of the findings problematic.  The 
review concluded that, although there is some evidence that pelvic floor exercises 
may help certain types of prolapse, further evidence from randomized controlled trials 
of the effectiveness of PFMT for the management of prolapse is required. 
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A further study, published more recently, Ghroubi [6], conducted a trial in 47 women 
with stage I or II cystocele. Women were randomized to a treatment group  (n=27) 
who received PFMT and advice on healthy  living or a no treatment group (n=20). 
Outcomes included clinical examination, the “Measurement of Urinary Handicap” 
scale, urodynamic tests and patient satisfaction. They reported that immediately post 
treatment, five women (19%) in the treatment group still complained of pelvic 
heaviness, compared with fourteen (70%) in the treatment group (p<0.001). Two 
years after the cessation of treatment 20 women from the intervention group retained 
benefits.  
 
 
This paper describes a pilot study for a multi-centre randomized controlled trial of the 
effectiveness of a PFMT intervention for women with stage I or II pelvic organ 
prolapse of any type, measured by the Pelvic Organ Prolapse Quantitation (POP-Q) 
system [7]. 
 
 
Materials and methods 
Recruitment 
Women attending outpatient gynaecology, urogynaecology and prolapse clinics at 
two Scottish teaching hospitals, with previously untreated prolapse of stage I or II 
(confirmed by their gynaecologist using the POP-Q [7]), were asked to participate in 
the trial.  Ethical approval was granted in the two centres (Southern General Hospital 
Ethics Committee; Paper no. EC/02/S/115; approved 25 September 2002 and 
Grampian Research Ethics Committee; Project no. 02/0243; approved 11 March 
2003). For all women, symptoms of prolapse were the main presenting problem. 
Consenting women were randomized by a remote telephone randomization system 
to receive individualised PFMT and lifestyle advice or a lifestyle advice leaflet.  Trial 
centre and number of births (none versus one or more) were applied as minimisation 
criteria.   
   
Intervention group 
The standardised intervention given to women in the PFMT group consisted of five 
appointments with a specialist women’s health physiotherapist over a 16-week period 
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(appointments at weeks 0, 2, 6, 11, 16).  At the first appointment, a standardised 
history was taken, and both a subjective prolapse assessment and internal pelvic 
floor muscle assessment (using the PERFECT scheme, including the modified 
Oxford scale [8]) were carried out.  Anatomy and function of the pelvic floor muscles 
were taught and types of prolapse described, using diagrams and a model pelvis.  
Women were also taught how to correctly contract the pelvic floor muscles and how 
to pre-contract the pelvic floor muscles against increases in intra-abdominal pressure 
(“the Knack” [9]). An individualised home exercise programme was prescribed and 
women were encouraged to perform six sets of exercises daily (based on individual 
muscle assessment, one set consisted of up to 10 maximum voluntary contractions 
held for up to 10 seconds, with 4 seconds rest between each contraction and 10 or 
more fast contractions in a row [8]), with the use of an exercise diary to record 
compliance.  A standardised lifestyle advice sheet was given to women (containing 
instructions on seeking advice where appropriate about weight loss, constipation, 
avoidance of heavy lifting, coughing and high impact exercise).  Where appropriate, 
tailored lifestyle advice was also given by the physiotherapist on ways of reducing 
intra-abdominal pressure to maximise the effects of the PFMT.  For example women 
were advised to change from high to low impact exercise and kneel instead of squat 
when gardening.  Where necessary the physiotherapist negotiated individual 
circumstances to find solutions to situations which were thought to be causing strain. 
Symptom changes, compliance with lifestyle advice and changes in pelvic floor 
muscle strength, assessed by vaginal examination, were recorded at each 
subsequent 30-minute consultation and the content of the home exercise programme 
adjusted accordingly. 
   
In order to standardise the physiotherapy intervention, a one-day course was 
developed and taught by one of the authors (DS) prior to the study starting.  Study 
physiotherapists already had clinical experience in PFMT.  The course therefore 
ensured consistency in: teaching of pelvic floor exercises (PFEs); pelvic floor muscle 
assessment; lifestyle advice; content of return appointments; use of diaries and 
standardised leaflets and use of standardised clinical documents to ensure a 
systematic consultation process.   
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Control group 
Women in the control group were sent a standardised lifestyle advice sheet 
immediately after randomization.  This leaflet was identical to that given to the 
intervention women. The control group did not see a physiotherapist, and had no 
planned contact with the hospital until the follow-up gynaecologist appointment. 
   
Outcome measurement 
Both groups of women completed postal questionnaires (available from the authors) 
at three time points (baseline i.e. immediately prior to randomization, 20 weeks after 
randomization, 26 weeks after randomization) and attended a return appointment 
with their gynaecologist at 20 weeks after randomization.   
 
The outcomes of primary interest were prolapse symptom severity and QoL 
measured via postal questionnaires [10] and the secondary outcome was prolapse 
severity (POP-Q) [7] measured by gynaecologists blind to the women’s study group 
allocation. The POP-Q consists of six defined points; two (Aa, Ba) on the anterior 
vaginal wall, two (C,D) at the superior vagina and two (Ap,Bp) on the posterior 
vaginal wall which are all measured in centimetres with respect to the hymen. In 
addition, the total vaginal length (with the prolapse reduced) is measured as well as 
the length of the genital hiatus and perineal body. It is the six internal measurements 
plus the total vaginal length which are used to calculate the stage of prolapse.  In 
addition, for intervention women only, pelvic floor muscle strength was measured, 
using the modified Oxford scale [8]. 
 
The postal questionnaires included: questions on prolapse symptoms and their 
impact; the International Consultation on Incontinence Questionnaire (ICIQ) urinary 
incontinence short form [11]; ICIQ bowel and the vaginal symptoms (an early version) 
modules [12] and the SF-12 [13].  The core content of the questionnaire remained 
the same at each time-point.  In addition, obstetric history data were gathered in the 
baseline questionnaire. 
 
Data Analysis 
Analysis of outcome measures was carried out in SPSS version 12 using Chi-square 
(for women’s subjective assessment of change in their prolapse), Fisher’s Exact (for 
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POP-Q stage), Mann-Whitney U (for POP-Q individual measurements) and Student’s 
unpaired t tests (for prolapse, urinary, bowel and sexual symptoms, prolapse-related 
QoL and pelvic floor muscle strength) to assess the relationship between group 
status (intervention/control) and the various outcomes of interest.  
 
 
Results 
Baseline characteristics 
Forty-seven women were randomized in the 14-month recruitment period from 
September 2003 to November 2004. The mean age of the group was 56 years (SD 
9).  All women had experienced at least one vaginal delivery, with the largest group 
(40%) having had 2 deliveries.  Fifty-five percent reported all spontaneous vaginal 
deliveries, and 45% reported at least one forceps delivery.  No caesarean sections 
were reported.  The most common type of prolapse was cystocele (85%), followed by 
rectocele (40%).  Forty-seven percent of women had one type of prolapse only, 45% 
had two and 8% had three.  The most common combination of prolapse types was 
cystocele and rectocele (30%). 
 
There were no significant differences with respect to age, parity, method of delivery, 
type or duration of prolapse, or prevalence of prolapse symptoms between the 
intervention and control groups at baseline. 
 
 
Recruitment, retention and compliance 
The response rate to questionnaires sent to women at 20 and 26 weeks (which were 
used to collect data for the primary outcomes) was 87% and 85% respectively, thus 
drop out from the study was low.  Eighty-nine percent of women attended their 20-
week gynaecology appointment where the follow-up POP-Q assessment was 
undertaken. 
 
In terms of compliance with intervention, most women in the intervention group (91%) 
attended at least three out of five physiotherapy appointments.  Attendance at later 
appointments was poorer (74% and 65% attended for appointments four and five 
respectively).  The average time to complete five appointments was 16 weeks (range 
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15 to 22 weeks).  For partial completers, the intervention time ranged from six to 12 
weeks.  Sixty-one percent of women were rated as good or moderate exercise 
compliers, based on their exercise diaries and information reported to the 
physiotherapist.   
 
 
Prolapse symptoms 
Women were asked how often they experienced various prolapse symptoms, with 
possible responses being never (0), a little of the time (1), some of the time (2), most 
of the time (3) and all of the time (4).  Prolapse symptoms were widely reported by 
study women (Table 1).  At baseline, the most commonly reported symptom was the 
feeling of something coming down (83% in the intervention group and 75% in the 
control group). 
 
A summary index, the Pelvic Organ Prolapse Symptom Score (POP-SS), was formed 
by summing the seven prolapse symptom responses (article describing the 
psychometric properties of the POP-SS is in press).  There was a significant 
difference between the intervention and control group in change in POP-SS score 
from baseline to 26-week follow-up (t = -2.298, df = 35, p = 0.021), indicating that 
intervention women had significantly greater improvement in symptoms than controls 
(mean score decrease 3.5 versus 0.1; 95% confidence interval for difference in mean 
score change [0.53, 6.21]) (Table 2). 
 
Women were asked to rate on a scale of 0 (not at all) to 10 (a great deal), how much 
their prolapse symptoms interfered with various aspects of their life (physical activity, 
social activity, personal hygiene, overall everyday life).  There were no significant 
differences between intervention and control group women in the scores for 
interference due to prolapse at 20 or 26 weeks. 
 
Women were asked at follow-up how they felt their prolapse was compared to the 
start of the study.  There were significant differences between the intervention and 
control group at both 20 (χ2 = 11.465, df = 1, p=0.001) and 26 weeks (χ2 = 6.320, df = 
1, p=0.012), with greater proportions of intervention women reporting their prolapse 
was better (Table 3). 
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Urine, bowel and vaginal symptoms 
Generally there were no significant differences between the intervention and control 
group in the main urine, bowel or vaginal symptoms at 20 or 26 weeks.  For example, 
change from baseline in the ICIQ urinary incontinence short form scores did not differ 
significantly between the intervention and control groups (Table 4). 
 
 
POP-Q measurements and prolapse severity  
Overall, complete POP-Q data was available for 57% of examinations. The 
percentage of women who had the summary POP-Q stage recorded was higher 
(91%), although the stage assigned was not always consistent with the reported 
POP-Q measurements from which it should have been derived. The POP-Q derived 
stage was used for analysis purposes. 
 
On five out of 42 occasions the group status of a woman was known to the 
gynaecologist when performing the follow-up POP-Q assessment.  Only three of 
these (1 intervention, 2 control) had associated baseline POP-Q data and therefore 
contributed data to the analysis; and for all three no change in POP-Q severity was 
recorded. 
 
Testing the difference between baseline and 20-week POP-Q showed significantly 
more improvement in the intervention group in the Aa and Ba measurements (Mann 
Whitney U test z = -2.099, p=0.036 and z = -2.677, p=0.007 respectively) (Table 5). 
  
A test of the difference in POP-Q stage (improved or not improved) from baseline to 
20 weeks showed significantly greater improvement in the intervention group 
(Fisher’s exact test p=0.038).  No control woman had any improvement recorded in 
her POP-Q severity (Table 6). 
 
Comparison of pelvic floor muscle strength at the first and fifth appointment was 
conducted (n = 15 women attended both these appointments).  There was evidence 
of an improvement in muscle strength in the group; mean muscle strength increased 
by 0.5, SD 0.6 (t = -3.09, df = 14, p = 0.008, 95% confidence interval [0.2, 0.8]). 
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Discussion  
This paper describes a study of the effectiveness of a PFMT intervention for women 
with pelvic organ prolapse.  The data presented here have been used to inform a 
definitive multi-centre trial to test the hypothesis that PFMT is effective in reducing 
prolapse symptoms, severity and the need for further treatment. 
 
Questionnaire response rates and follow-up clinic attendance rates in our study were 
high.  Despite the small number of women in the study, data analysis results 
indicated a positive effect of the intervention on prolapse symptoms and severity. 
 
Prolapse symptoms improved significantly more in the PFMT group, and these 
women were also more likely to say their prolapse was better at follow-up compared 
to the start of the study.  However, no differences were detected between the groups 
in terms of how much their prolapse interfered with daily life.  This may be due to the 
specific prolapse symptom questions being more sensitive than those on life 
interference, and the small sample size.  Ghroubi [6] also found a significant 
reduction in prolapse symptoms (pelvic heaviness) in a PFMT group compared to no 
treatment group in a study of 47 women with stage I or II cystocele.  
Because of the lack of trials in this area, no other data have been published for 
comparison.  
 
A greater improvement in two of the POP-Q measurements (Aa and Ba) was 
detected in the intervention group.  This suggests that prolapse in the anterior 
compartment may have improved in the intervention group.  Since 85% of women in 
the study had a cystocele, improvements might have been expected in this area.  
Benefits were also found in terms of overall prolapse severity.  Only intervention 
women showed an improvement in their POP-Q stage (5 out of 11 intervention 
women improved versus 0 out of 9 controls); control women’s stage remained either 
unchanged or worsened.  Piya-Anant [5] also reported positive findings from their 
sizeable trial of pelvic floor exercises plus dietary/fluid advice for anterior prolapse. In 
the group with mild anterior prolapse the rate of prolapse worsening at 12 months 
was significantly less for intervention women.  The rate of worsening of severe 
anterior prolapse was significantly less in the intervention group than the control after 
24 months.  Although the study populations are not directly comparable, and the 
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Piya-Anant trial did not use the POP-Q method of assessment, it is interesting that 
both indicate a benefit from conservative intervention. Similarly, a significant change 
in prolapse symptoms were seen by Ghroubi [6] in a study of 47 women with stage I 
and II cystocele, however again the POP-Q was not used as an outcome measure so 
a direct comparison cannot be made. 
 
 
Women in this study who were randomized to PFMT had increased pelvic floor 
muscle strength by their final appointment.  Improvements in pelvic floor muscle 
strength and coordination are the aims of PFMT.  Such muscle changes may improve 
the support of the pelvic organs and counteract increases in intra-abdominal 
pressure.  There is evidence that PFMT results in increases in pelvic floor muscle 
strength, and subsequently improvements in symptoms, in women with urinary 
incontinence [3]. Applying the same principle, improvements in prolapse symptoms 
might also be expected as a result of PFMT [14].  The PFMT intervention evaluated 
is based on evidence for prescribing an individual pelvic floor muscle exercise 
regimen to improve strength, endurance and co-ordination [8,9]. This regimen is 
currently used by UK physiotherapists for conservative management of urinary 
incontinence [15,16] and prolapse [2].  The intervention duration of 16 weeks was 
based on the minimum time required for physiological muscle strength changes to 
occur [16,17].  Exercise regimens were reviewed and progressed following a 
PERFECT [8] examination at each physiotherapy appointment.  The examination 
includes a method of pelvic floor muscle assessment which has been shown to be 
reliable in the lying position with bent knees [8,18] as was the standardized position 
for this study.  
In this study pelvic floor muscle strength was measured by the same physiotherapist 
providing the intervention, thus bias may have been introduced. Pelvic floor muscle 
strength was not measured in the control group.  The rationale for this was the desire 
to avoid an unintentional training effect in this group, which potentially would have 
diluted the intervention effect. However it is a limitation of the study that we cannot 
conclude whether there was an association between the change in pelvic floor 
muscle strength and the positive effect of the intervention as we have no comparable 
data on pelvic floor muscle change (or not) in the control group. 
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Due to the pilot nature of this study the sample size was small and the duration of 
follow-up short.  The focus was on developing the trial methods and gathering data to 
inform future sample size calculations.   
 
POP-Q data were often incomplete leading to reduced numbers in the analysis. This 
may have been due to time constraints at clinics, lack of familiarity with the POP-Q 
and lack of appreciation of the importance of this data to the study.  Since symptoms 
and QoL rather than anatomical variables were the primary outcomes the lack of 
some POP-Q data is of secondary importance.  However the issue does need to be 
addressed and the provision of thorough training and support for medical staff in 
using the POP-Q requires consideration in future trials.  Successful blinding of 
gynaecologists during POP-Q assessment was a challenge in this study, and 
methods for optimizing this process are needed.   
 
This study found a greater improvement in prolapse symptoms in women randomized 
to PFMT than to control.  This study also found that those women randomized to 
PFMT had an objective improvement in POP-Q measurement compared to no such 
improvement in those randomized to control.  In addition, pelvic floor muscle strength 
was improved in the intervention group.  Due to the small sample size and limited 
follow-up time further research is necessary to confirm or refute the results.  A large 
multi-centre trial of PFMT, with a minimum of one year follow-up, has now 
commenced. 
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Tables 
 
Table 1 Prolapse symptoms reported in baseline, 20- and 26-week questionnaires (% 
indicating symptom present “a little of the time” or more) 
 PFMT Control 
Prolapse symptoms Baseline 
(n = 23) 
20week 
(n = 19) 
26week 
(n = 19) 
Baseline 
(n = 24) 
20week 
(n = 22) 
26week 
(n = 21) 
Feeling of something coming 
down from or in your vagina? 
83 90 63 75 86‡ 67 
Uncomfortable feeling or pain 
in your vagina which is worse 
when standing? 
73# 79 63 63 59 57 
Heaviness or dragging feeling 
in your lower abdomen / 
tummy?    
61 44* 58 67 62‡ 55† 
Heaviness or dragging feeling 
in your lower back? 
61 74 53 58 71‡ 76 
Need to strain (push) to empty 
your bladder? 
60# 42 53 54 73 67 
Feeling that your bladder has 
not emptied completely? 
61 58 53 67 77 71 
Feeling that your bowel has not 
emptied completely? 
57 63 53 71 68 57 
# n = 22; * n = 18; † n = 20; ‡ n = 21, otherwise n for cell is the same as for column 
 
 
 
 
 
 
 
 
 17 
Table 2  Change in prolapse symptom score* 
 Change Group  n Mean SD Unpaired t 
p value 
20 wks-baseline PFMT 17 -1.94 4.8 0.080 
  Control 20 0.40 3.0 
26 wks-baseline PFMT 17 -3.47 5.4 0.021 
    Control 20 -0.10 2.9 
*sum of 7 symptom questions, min. 0=no symptoms, max. 28=all symptoms 
present all the time 
 
 
 
Table 3  Self-reported change in prolapse since start of study (frequency (%)) 
 PFMT Control 
 20-week 
(n=19) 
26-week 
(n=19) 
20-week 
(n=21) 
26-week 
(n=21) 
the same or 
worse 
9 (47) 7 (37) 20 (95) 16 (76) 
better 10 (53) 12 (63) 1 (5) 5 (24) 
 
 
Table 4  Change in ICIQ urinary incontinence short-form scores* 
    N Mean SD Unpaired t 
p value 
20 wks-baseline PFMT 19 -0.21 3.2 0.494 
  Control 21 0.48 3.0   
26 wks-baseline PFMT 19 -1.79 3.2 0.070 
  Control 20 0.00 2.8   
* min. score 0, max. score 21; higher scores indicate greater leakage and  
associated bother 
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Table 5 Mean difference* (20 weeks - baseline) in measurements for women with 
complete POP-Q data (n = 20) 
Difference in 
site 
specific points: 
PFMT 
(n=11) 
Control 
(n=9) 
Aa - 0.36 cm   0.67 cm 
Ba - 1.09 cm   0.56 cm 
Ap   0.18 cm   1.44 cm 
Bp - 0.18 cm   1.11 cm 
C   0.10 cm   0.75 cm 
D   0.20 cm   0.75 cm 
* A negative value indicates an improvement at 20 weeks. n varies as some women 
had only partial POP-Q data. 
 
 
Table 6 Change* in severity stage from baseline to 20-week assessment for women 
with complete POP-Q data (n = 20) (frequency (%)) 
Change in stage PFMT 
(n=11) 
Control 
(n=9) 
+2 stages 0  (  0) 0  (  0) 
+1 stages 1  (  9) 3  (33) 
no change in stage 5  (45) 6  (67) 
-1 stage 4  (36) 0  (  0) 
-2 stage 1  (  9) 0  (  0) 
* A negative value indicates an improvement at 20 weeks. 
 
 
 
 
 
